Adicet Bio Inc (ACET) Event Aug. 10, 2022, 00:00 UTC (42% Neutral) Adicet Bio, Inc. (ACET) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 8:35 p.m. 🏢 Adicet Bio Inc (ACET) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-10 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-10.85M $-10.85M N/A +0.00% ➡️ Total Assets $338.94M $329.90M $9.03M +2.74% ↗️ Total Liabilities $35.81M $36.64M $-828.00K -2.26% ↘️ Stockholders' Equity $228.34M $-138.50M $366.84M +264.87% 📈 Operating Income/Loss $-32.18M $-18.00M $-14.18M -78.77% 📈 R&D Expense $22.36M $29.66M $-7.30M -24.62% 📈 Earningspersharebasic $-1.11 $-0.45 $-0.66 -146.67% 📉 Earningspersharediluted $-1.11 $-0.45 $-0.66 -146.67% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Adicet Bio Inc (ACET) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document